The Netflix series has been praised by many as being “revolutionary” in its depictions of womanhood, but the show fails to offer its Black characters the sexual liberation that is typically only associated with white characters.
The historic Obergefell v. Hodges decision affirming marriage equality marks an important early step in the fight for gender equality.
After years of controversy, sex education will now be mandatory in Hawaii schools just as data suggests recent efforts to improve sex ed have worked to reduce teen pregnancy and abortion rates.
In truth, because trans people are often forced to remain silent out of fear, any attempt to stand up for ourselves and counter conventional wisdom is seen by some members of the public as the so-called mob descending.
“The exclusion of methods used by men simply makes no sense and benefits no one—not men, not women, not families, not health plans,” Adam Sonfield, author of a new analysis for the Guttmacher Institute on “male” contraceptive methods, said in a statement.
The lack of LGBTQ-inclusive, comprehensive, and medically accurate sexual and reproductive health education is a public health concern that many lawmakers, educators, and doctors are letting slip through the cracks.
The Rhode Island Department of Health recently announced that rates of HIV, gonorrhea, and syphilis are up across the state. Though media reports focused on the role of hook-up apps, such as Tinder and Grindr, the department attributes the rise to both better testing and a host of high-risk behaviors.
This week, teens get health and sex information on the web, condom demonstrations are allowed in New York City public school health classes, and a British woman serves time for being too loud.
Stemming the tide of barriers to reproductive health care continues to require significant time and effort from countless dedicated individuals and organizations. It is hard work, but it is work worth doing to ensure that everyone has the ability to choose whether and when to have a child.
An FDA advisory panel recommended Thursday that the agency approve flibanserin, a drug that has often been called the female Viagra.